D r. Peter Marks is the kind of health official both Democrats and Republicans used to admire. He served in the U.S. Food and Drug Administration (FDA) for 13 years, most of them as director of the Center for Biologics Evaluation and Research. There, Marks oversaw the critical process of reviewing and approving vaccines—like those against COVID-19—and biologic therapies, including gene- and cell-based treatments. Marks earned trust and respect from academic and industry scientists as well for

Tag-uri: Coronavirus